Clinical Trial: Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A 5-Day, Double-Blind, Placebo-Controlled Multicenter Study of Oral YM087 (CI-1025) to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia

Brief Summary: Study of efficacy & safety of oral YM087 in subjects with euvolemic or hypervolemic hyponatremia

Detailed Summary:
Sponsor: Cumberland Pharmaceuticals

Current Primary Outcome: Change in serum sodium from Baseline Safety of each dosing regimen [ Time Frame: Beginning through end of treatment ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Cumberland Pharmaceuticals

Dates:
Date Received: June 25, 2007
Date Started: January 2000
Date Completion:
Last Updated: April 30, 2014
Last Verified: April 2014